The Role of Novel Prognostic Scores for Patients With Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.06.959
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognostic Scores for Sorafenib-Treated Hepatocellular Carcinoma Patients: A New Application for the Hepatoma Arterial Embolisation Prognostic Score

European Journal of Cancer
Cancer ResearchOncology
2017English

Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients With Hepatocellular Carcinoma Underwent Hepatectomy

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Prognostic Role of Noninvasive Liver Reserve Markers in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

PLoS ONE
Multidisciplinary
2017English

SLC2A2 (GLUT2) as a Novel Prognostic Factor for Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Prognostic Role of ABO Blood Group and Rhesus Factor in Cirrhotic Patients With Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2019English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

SAC3D1: A Novel Prognostic Marker in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2018English

A Prognostic Score for Patients With Intermediate-Stage Hepatocellular Carcinoma Treated With Transarterial Chemoembolization

PLoS ONE
Multidisciplinary
2015English

Prognostic Factors for Hepatocellular Carcinoma Recurrence

World Journal of Gastroenterology
MedicineGastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy